|
| | Levothyroxine Impurity 16 Basic information |
| Product Name: | Levothyroxine Impurity 16 | | Synonyms: | Levothyroxine Impurity 16;(2S)-2-amino-3-[3-chloro-4-(4-hydroxy-3,5-diiodophenoxy)-5-iodophenyl]propanoic acid;Levothyroxine Impurity 10;Levothyroxine?Monochloro Impurity;3-Chloro-3’,5,5’-triiodo-L-thyronine;Monochlorotriiodothyronine;Levothyroxine Impurity 3;Levothyroxine Impurity 4 | | CAS: | 909279-46-5 | | MF: | C15H11ClI3NO4 | | MW: | 685.42 | | EINECS: | | | Product Categories: | | | Mol File: | 909279-46-5.mol |  |
| | Levothyroxine Impurity 16 Chemical Properties |
| Melting point | >194°C (dec.) | | Boiling point | 539.4±50.0 °C(Predicted) | | density | 2.408±0.06 g/cm3(Predicted) | | storage temp. | Amber Vial, -20°C Freezer, Under inert atmosphere | | solubility | Aqueous Base (Slightly, Heated), DMSO (Slightly, Heated) | | form | Solid | | pka | 2.12±0.30(Predicted) | | color | Pale Beige to Beige | | Stability: | Light Sensitive |
| | Levothyroxine Impurity 16 Usage And Synthesis |
| Uses | 3-Chloro-3’,5,5’-triiodo-L-thyronine is a chlorinated derivative of 3,3’,5’-Triiodo-L-thyronine (T795350), used for the early detection and treatment of congenital or drug-induced hypothyroidism in the developing human fetus. |
| | Levothyroxine Impurity 16 Preparation Products And Raw materials |
|
